Stock 688566 JIANGSU JIBEIER PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Jiangsu Jibeier Pharmaceutical Co., Ltd. Stock

Equities

688566

CNE100004041

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 2025-01-23 		5-day change 1st Jan Change
22.03 CNY +0.36% Intraday chart for Jiangsu Jibeier Pharmaceutical Co., Ltd. +0.73% -1.65%
Oct. 30 Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024 CI
Sep. 03 Jibeier Pharmaceutical Gets Nod to Market Lomefloxacin Hydrochloride MT

Valuation: Jiangsu Jibeier Pharmaceutical Co., Ltd.

Capitalization 4.39B 603M 579M 547M 489M 867M 52.11B 960M 6.64B 2.44B 21.49B 2.26B 2.21B 94.03B P/E ratio 2024 *
15.6x
P/E ratio 2025 * 12.7x
Enterprise value 4.39B 603M 579M 547M 489M 867M 52.11B 960M 6.64B 2.44B 21.49B 2.26B 2.21B 94.03B EV / Sales 2024 *
4.18x
EV / Sales 2025 * 3.44x
Free-Float
26.52%
Yield 2024 *
1.18%
Yield 2025 * 1.41%
More valuation ratios * Estimated data

Chart: Jiangsu Jibeier Pharmaceutical Co., Ltd.

Dynamic Chart

Latest news: Jiangsu Jibeier Pharmaceutical Co., Ltd.

Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024 24-10-30 CI
Jibeier Pharmaceutical Gets Nod to Market Lomefloxacin Hydrochloride 24-09-03 MT
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 24-08-29 CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. announced that it has received CNY 198.161716 million in funding from a group of investors 24-06-04 CI
Jibeier Pharmaceutical Gets Patents for Two Products 24-05-21 MT
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 24-04-25 CI
Jibeier Pharmaceutical's Taxane Compound Method Gets Patent; Shares Down 3% 24-04-08 MT
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 24-02-25 CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 23-10-30 CI
Jiangsu Jibeier Pharmaceutical Co., Ltd.(XSSC:688566) added to S&P Global BMI Index 23-09-18 CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 23-08-29 CI
Jiangsu Jibeier Pharmaceutical Co., Ltd. announced that it expects to receive CNY 298.1619 million in funding 23-06-01 CI
Certain A Shares of Jiangsu Jibeier Pharmaceutical Co., Ltd. are subject to a Lock-Up Agreement Ending on 18-MAY-2023. 23-05-17 CI
More news

Quotes and Performance

1 day+0.36%
1 week+0.73%
Current month-1.65%
1 month-2.39%
3 months-11.21%
6 months+3.43%
Current year-1.65%
More quotes

Course Extremes

1 week
21.83
Extreme 21.83
22.33
1 month
21.60
Extreme 21.6
22.85
Current year
21.60
Extreme 21.6
22.70
1 year
17.49
Extreme 17.49
30.20
3 years
14.98
Extreme 14.98
41.96
5 years
14.98
Extreme 14.98
54.97
10 years
14.98
Extreme 14.98
54.97
More quotes

Managers and Directors: Jiangsu Jibeier Pharmaceutical Co., Ltd.

Director TitleAgeSince
Zhong yi Geng CEO
 Chief Executive Officer 62 2014-09-24
Suo Fu Zhao DFI
 Director of Finance/CFO 58 2017-05-07
Xiu Gen Wu CTO
 Chief Tech/Sci/R&D Officer 60 2008-06-30
Manager TitleAgeSince
Zhong yi Geng CHM
 Chairman 62 2001-11-12
Xin Jun Yu BRD
 Director/Board Member 64 2001-11-12
Tao Hu BRD
 Director/Board Member 48 2013-02-28
More insiders

Specialty & Advanced Pharmaceuticals

Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 Change 5d. change 1-year change 3-years change Capi. ($)
JIANGSU JIBEIER PHARMACEUTICAL CO., LTD. Stock Jiangsu Jibeier Pharmaceutical Co., Ltd.
+0.36%+0.73%-13.88%+0.32%603M
MERCK KGAA Stock Merck KGaA
+0.73%+2.83%-1.02%-23.50%65.36B
KYOWA KIRIN CO. LTD. Stock Kyowa Kirin Co. Ltd.
+0.96%+1.27%-2.63%-21.59%7.48B
HALOZYME THERAPEUTICS, INC. Stock Halozyme Therapeutics, Inc.
+0.63%+0.47%+60.09%+64.15%7.08B
YUHAN CORPORATION Stock Yuhan Corporation
-1.16%-5.96%+112.46%+139.41%6.67B
SK BIOPHARMACEUTICALS CO., LTD. Stock SK Biopharmaceuticals Co., Ltd.
-0.09%-3.46%+18.67%+27.58%5.93B
BETTA PHARMACEUTICALS CO., LTD. Stock Betta Pharmaceuticals Co., Ltd.
-3.12%+4.42%+33.49%-20.44%3.19B
SUPERNUS PHARMACEUTICALS, INC. Stock Supernus Pharmaceuticals, Inc.
+1.23%+2.03%+39.39%+30.32%2.13B
SHANGHAI SHYNDEC PHARMACEUTICAL CO., LTD. Stock Shanghai Shyndec Pharmaceutical Co., Ltd.
-0.26%+1.95%+34.07%+22.92%2.12B
SHENYANG XINGQI PHARMACEUTICAL CO.,LTD. Stock Shenyang Xingqi Pharmaceutical Co.,Ltd.
+0.11%+0.13%-34.45%+16.45%1.69B
Average -0.06%-0.12%+24.62%+23.56% 10.23B
Weighted average by Cap. +0.45%+0.22%+13.66%-0.72%
See all sector performances

Financials

2024 *2025 *
Net sales 1.05B 144M 139M 131M 117M 207M 12.47B 230M 1.59B 584M 5.14B 541M 530M 22.5B 1.28B 175M 168M 159M 142M 252M 15.15B 279M 1.93B 710M 6.25B 657M 644M 27.34B
Net income 272M 37.35M 35.88M 33.92M 30.27M 53.7M 3.23B 59.49M 411M 151M 1.33B 140M 137M 5.83B 335M 45.92M 44.11M 41.7M 37.22M 66.02M 3.97B 73.14M 506M 186M 1.64B 172M 169M 7.16B
Net Debt - -
More financial data * Estimated data

Company Profile

Logo Jiangsu Jibeier Pharmaceutical Co., Ltd.
Jiangsu Jibeier Pharmaceutical Co Ltd is a company engaged in the research, development, production and sales of drugs. The Company's products are comprised of tablets, capsules and eye drops. The tablet products include Leucogen tablets, Nitrendipine and Atenolol tablets, Aceclofenac Enteric-coated tablets and Asarone tablets. The Company's products are used to improve white blood cells, treat high blood pressure, eye infections and other diseases.
Employees
1,445
Sector
Pharmaceuticals
Calendar
2025-04-23 - Q1 2025 Earnings Release (Projected)
More about the company

Quotes

Date Price Change Volume
25-01-23 22.03 ¥ +0.36% 593,068
25-01-22 21.95 ¥ -0.86% 473,006
25-01-21 22.14 ¥ -0.09% 366,257
25-01-20 22.16 ¥ +1.00% 564,968
25-01-17 21.94 ¥ +0.32% 470,774

End-of-day quote Shanghai S.E., January 22, 2025

More quotes

Income Statement and Estimates

income-statement-evolution-chart JIANGSU-JIBEIER-PHARMACEU More financial data

Ratings

Trading Rating
Investor Rating
ESG MSCI
surperformance-ratings-light-chart JIANGSU-JIBEIER-PHARMACEUMore Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
22.03
Average target price
-
Consensus
Profit revisions
estimates-change-chart JIANGSU-JIBEIER-PHARMACEU Estimate revisions

Annual profits - Rate of surprise

quality-estimates-chart JIANGSU-JIBEIER-PHARMACEU Company calendar
  1. Stock Market
  2. Equities
  3. 688566 Stock